Marty M - Search Results

1

High-dose-rate brachytherapy for early breast cancer: an ambulatory technique.

Hennequin C, Durdux C, Espié M, Balla-Mekias S, Housset M, Marty M, Chotin G, Maylin C. Hennequin C, et al. Among authors: marty m. Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):85-90. doi: 10.1016/s0360-3016(99)00139-x. Int J Radiat Oncol Biol Phys. 1999. PMID: 10477010

2

[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast].

Culine S, Extra JM, Espie M, Bourstyn E, Dieras V, Giacchetti S, Maylin C, De Rocquancourt A, Morvan F, Marty M. Culine S, et al. Among authors: marty m. Bull Cancer. 1993 Nov;80(11):994-1000. Bull Cancer. 1993. PMID: 8081037 French.

3

Prognostic significance of a combined clinicopathologic score for response to primary systemic therapy in locally advanced breast cancer.

Bertheau P, Lerebours F, Mounier N, de Roquancourt A, Espié M, Clot P, Servant JM, Misset JL, Marty M, Janin A. Bertheau P, et al. Among authors: marty m. Oncol Rep. 2005 Aug;14(2):513-20. Oncol Rep. 2005. PMID: 16012739

4

[Isolated internal breast adenopathy. Late recurrence of breast cancer].

Tredaniel J, Espie M, Extra JM, Marty M. Tredaniel J, et al. Among authors: marty m. Rev Pneumol Clin. 1988;44(2):110-2. Rev Pneumol Clin. 1988. PMID: 3406617 French.

5

[Radiological location of infraclinical lesions of the breast. Technique--results--therapeutic consequences].

Bourstyn E, Marty M, Espie M, de Roquancourt A, Laval-Jeantet M, Clot P. Bourstyn E, et al. Among authors: marty m. Chirurgie. 1994-1995;120(6-7):342. Chirurgie. 1994. PMID: 7768122 French. No abstract available.

6

[Inflammatory cancer of the breast: review and experience at Saint-Louis hospital].

Espié M, Extra JM, de Roquancourt A, Bourstyn E, Hennequin C, Morvan F, Marty M. Espié M, et al. Among authors: marty m. Arch Anat Cytol Pathol. 1995;43(1-2):36-43. Arch Anat Cytol Pathol. 1995. PMID: 7794025 Review. French.

7

Prospects with docetaxel in the treatment of patients with breast cancer.

Marty M, Extra JM, Cottu PH, Espié M. Marty M, et al. Eur J Cancer. 1997 Aug;33 Suppl 7:S26-9. doi: 10.1016/s0959-8049(97)90007-1. Eur J Cancer. 1997. PMID: 9486101 Review.

8

Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

Degeorges A, de Roquancourt A, Extra JM, Espie M, Bourstyn E, de Cremoux P, Soussi T, Marty M. Degeorges A, et al. Among authors: marty m. Breast Cancer Res Treat. 1998 Jan;47(1):47-55. doi: 10.1023/a:1005824216444. Breast Cancer Res Treat. 1998. PMID: 9493975 Clinical Trial.

9

Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.

Ardavanis A, Extra JM, Espié M, Cuvier C, Marty M. Ardavanis A, et al. Among authors: marty m. In Vivo. 1998 Sep-Oct;12(5):559-62. In Vivo. 1998. PMID: 9827368 Clinical Trial.

10

Optimizing chemotherapy for patients with advanced breast cancer.

Marty M, Espie M, Cottu PH, Cuvier C, Lerebours F. Marty M, et al. Oncology. 1999 Jul;57 Suppl 1:21-6. doi: 10.1159/000055265. Oncology. 1999. PMID: 10436413 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

796 results

Search Page

Filters